Kelly Kearney
FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B
Health Industry Washington Watch ·
FDA and DEA seek to ameliorate the shortage and misuse of stimulants
Health Industry Washington Watch ·
OIG approves arrangement involving a testamentary gift to a nonprofit hospital to reduce costs for pediatric patients
Health Industry Washington Watch ·
CMS acknowledges improvement in nursing home COVID-19 response, eliminates certain blanket waivers
Health Industry Washington Watch ·
Open for business in 2021
Health Industry Washington Watch ·